168 related articles for article (PubMed ID: 26759222)
1. Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
Cang S; Xu X; Ma Y; Liu D; Chiao JW
J Hematol Oncol; 2016 Jan; 9():3. PubMed ID: 26759222
[TBL] [Abstract][Full Text] [Related]
2. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
[TBL] [Abstract][Full Text] [Related]
3. Different effect of sodium butyrate on cancer and normal prostate cells.
Paskova L; Smesny Trtkova K; Fialova B; Benedikova A; Langova K; Kolar Z
Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
5. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
Fialova B; Smesny Trtkova K; Paskova L; Langova K; Kolar Z
Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
[TBL] [Abstract][Full Text] [Related]
6. Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells.
Cang S; Feng J; Konno S; Han L; Liu K; Sharma SC; Choudhury M; Chiao JW
Int J Oncol; 2009 Dec; 35(6):1417-22. PubMed ID: 19885564
[TBL] [Abstract][Full Text] [Related]
7. A new approach combining LC-MS and multivariate statistical analysis for revealing changes in histone modification levels.
Bilgraer R; Gillet S; Gil S; Evain-Brion D; Laprévote O
Mol Biosyst; 2014 Nov; 10(11):2974-83. PubMed ID: 25167371
[TBL] [Abstract][Full Text] [Related]
8. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of post-translational modifications of human histones.
Beck HC; Nielsen EC; Matthiesen R; Jensen LH; Sehested M; Finn P; Grauslund M; Hansen AM; Jensen ON
Mol Cell Proteomics; 2006 Jul; 5(7):1314-25. PubMed ID: 16627869
[TBL] [Abstract][Full Text] [Related]
11. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
Krautkramer KA; Reiter L; Denu JM; Dowell JA
J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
[TBL] [Abstract][Full Text] [Related]
12. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.
Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases.
Lillico R; Sobral MG; Stesco N; Lakowski TM
J Proteomics; 2016 Feb; 133():125-133. PubMed ID: 26721445
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.
Nightingale KP; Gendreizig S; White DA; Bradbury C; Hollfelder F; Turner BM
J Biol Chem; 2007 Feb; 282(7):4408-4416. PubMed ID: 17166833
[TBL] [Abstract][Full Text] [Related]
15. Extensive and varied modifications in histone H2B of wild-type and histone deacetylase 1 mutant Neurospora crassa.
Anderson DC; Green GR; Smith K; Selker EU
Biochemistry; 2010 Jun; 49(25):5244-57. PubMed ID: 20462202
[TBL] [Abstract][Full Text] [Related]
16. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
[TBL] [Abstract][Full Text] [Related]
17. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
de Conti A; Tryndyak V; Koturbash I; Heidor R; Kuroiwa-Trzmielina J; Ong TP; Beland FA; Moreno FS; Pogribny IP
Carcinogenesis; 2013 Aug; 34(8):1900-6. PubMed ID: 23568954
[TBL] [Abstract][Full Text] [Related]
18. TR-FRET cellular assays for interrogating posttranslational modifications of histone H3.
Machleidt T; Robers MB; Hermanson SB; Dudek JM; Bi K
J Biomol Screen; 2011 Dec; 16(10):1236-46. PubMed ID: 21972037
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry.
Lee AY; Paweletz CP; Pollock RM; Settlage RE; Cruz JC; Secrist JP; Miller TA; Stanton MG; Kral AM; Ozerova ND; Meng F; Yates NA; Richon V; Hendrickson RC
J Proteome Res; 2008 Dec; 7(12):5177-86. PubMed ID: 19367703
[TBL] [Abstract][Full Text] [Related]
20. [Experiment study of PHI on histone methylation and acetylation in Molt-4 cells].
Huang YQ; Ma XD; Zhen RJ; Chiao JW; Liu DL
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):612-5. PubMed ID: 18246819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
